Effectiveness of Rasayana therapy in CA Lung (Sqamous cell carcinoma)

Size: px
Start display at page:

Download "Effectiveness of Rasayana therapy in CA Lung (Sqamous cell carcinoma)"

Transcription

1 Effectiveness of Rasayana therapy in CA Lung (Sqamous cell carcinoma) Yogesh Bendale,Vineeta Bendale and Pravin Gund Rasayu Cancer Clinic Pune Abstract: Complete tumor regression was achieved in present case only by Ayurveda therapies. Our case report illustrates the potential role of curative intent medicine AMURT in lung cancer. So Increased survival of Patient is also highlighted by the current case study. The present study indicates that Rasayana therapy is effective in the treatment of Lung Cancer and did not produce any toxic side effects. However, proper clinical trials with large samples are needed to substantiate the observations so that beneficial alternative therapies can be integrated with conventional care. Key Words: CA Lung, Ayurveda, Sqamous cell carcinoma, INTRODUCTION Lung cancer is a major problem in both developed and developing countries in the world. [1] Lung cancer is one of the common differential diagnosis for weight loss, lung mass, pleural effusion with lymph adenopathy in a male smoker in our country [2][3]. Lung cancer is broadly divided into two types small cell and non-small cell. This general histological classification reflects the clinical and biological behavior of these distinct tumor types. The diagnosis requires high index of suspicion as it can be easily confused with tuberculosis and chronic bronchitis. Tobacco (Smoking/chewing) is the single most important risk factor for all types of lung cancers.

2 The standard management of lung cancer with good performance status is Radiotherapy and palliative chemotherapy. Because of side effects and complications of Radiotherapy and chemotherapy [4], alternative therapy including Ayurveda is good option to manage cancer. Here we would like to discuss Ayurveda treatment for lung cancer and present an unusual case of Lung cancer which is successfully treated by Ayurveda Rasayana therapy CASE REPORT A 89 years old male patient from Hyderabad, chronic tobacco chewer, presented with history of Adeno carcinoma and opacities in upper zone of left lung and diagnosed with CA Lungs.(Sqamouscell carcinoma). There were no symptoms of breathing difficulty, hemoptysis, bony pains, or lumps noticed anywhere in body. Brain, abdomen and bones are normal. Evaluation included a contrast-enhanced computed tomography (CT) of thorax. Our patient presented to us with a CT scan showing a left upper lobe mass lesion 4.6 * 3.6. His vitals were normal, physical examination was unremarkable, and TNM Staging was T2 N2 M0. X-Ray chest showed opacities in left upper zone. FNAC showed poorly differentiated Adeno carcinoma. PET CT showed intense FDG Uptake (SUV max 25) noted in left lung and in mediastinal nodes. Patient received Radiotherapy(RT) for 2 months. Post RT there was a significant reduction in lesion. PET Scan showed lesion measuring 2.9 x 2.8 x 3.0. PET CT showed further significant reduction in left upper lobe and mediastinal nodes. Persistent uptake was seen in primary and mediastinal nodes. Hence further he was adviced to take Chemotherapy. Patient took only one cycle of Chemotherapy but he could not tolerate the CT. Patient refused to take further CT because of severe adverse reactions. The Patient approached us for Ayurved Treatment. After detailed history and physical examination, laboratory investigations, we started AMURT (An exclusive Ayurved Treatment/formulation). The patient was counseled in detail regarding the treatment of Ayurveda.Patient was treated with herbo mineral ayurveda formulations (Table 1). After taking Ayurved treatment X-Ray chest showed homogenous opacity in left lower zone. HRCT - No tumor was seen in this study, Bilateralplureal effusion and ill defined fibrosis seen. There was significant symptomatic relief after Ayurved treatment. Treatment was continued as same. Further X-Ray showed only chronic kochs lesion with fibrosis in both lungs with pleural thickening. Recent X-Ray showed bilateral pleural thickening with chronic Kochs. The patient

3 is now alive and free of disease and Patient s present age is 92 years. He is healthy and leading a good QOL. After 4 years of diagnosis the patient is still taking Ayurveda Rasayana treatment. Table -1.Medcines prescribed to the patient Formulation Anupana Dosage Rasa kalpa in capsule form Hirakabhasma Honey 10 mg BD Suvarnasindoor Honey 50 mg BD Ahrakabhasma Honey 50 mg BD Sameerpannag rasa Honey 75 mg BD Combination choorna Sitopaladichoorna Yashtimadhu Tribhuvankirti Rasa 75 mg BD Shwaskuthar Rasa 25 mg Bd Arogyavardhini Warm water Shunthi Tulsi Bhruhati Tankanabhasma 75 MG BD Discussion CA Lungs is a very dreadful disease. Still there is no much satisfactory answer for it when diagnosed very late, hence multiple therapeutic approach is necessary to eradicate the disease. Chest and abdomen CT and PET scans are routinely performed in patients with suspected metastatic lung cancer. Integrated CT/PET has better sensitivity and specificity than CT or PET alone.[5] PET/CT has good sensitivity and specificity in identifying distant metastases.[6] Assessment of pathological response to treatment has played an important role. Those patients who achieve complete pathological response have long-term survival advantage.[7] The common histological features of tumor regression are coagulative necrosis, fibrosis, foam cell/giant cell

4 reaction, as well as mixed inflammatory infiltrate. The amounts of fibrosis correlate well with extent of tumor regression, which in turn is a surrogate marker of tumor response. Squamous carcinoma was associated with a higher probability of treatment response than other carcinoma.[7]our patient was treated as CA Lungs.(Sqamous cell carcinoma) with curative intent as a deviation from established guidelines. In the absence of other distant metastases, he was given Ayurveda Rasayana thereapy. Complete pathological remission and tumor regression was achieved which has been rarely reported in literature. No major side effects were noticed in treatment duration, liver and kidney function tests were kept normal. An Ayurvedic approach like the one given here can be of some help to the cancer patients. CONCLUSION Complete tumor regression was achieved in present case only by Ayurveda therapies. Our case report illustrates the potential role of curative intent medicine AMURT in lung cancer. So Increased survival of Patient is also highlighted by the current case study. The present study indicates that Rasayana therapy is effective in the treatment of Lung Cancer and did not produce any toxic side effects. However, proper clinical trials with large samples are needed to substantiate the observations so that beneficial alternative therapies can be integrated with conventional care. Acknowledgement: Authors sincerely acknowledge the efforts of Dr Anand Kulkarni, Mumbai in preparing the manuscript. REFERENCES [1] WHO World Cancer Report 2014 [2] Horn, L; Pao W; Johnson DH (2012). "Chapter 89". In Longo, DL; Kasper, DL; Jameson, JL; Fauci, AS; Hauser, SL; Loscalzo, J.Harrison's Principles of Internal Medicine (18th ed.). McGraw-Hill. ISBN X. [3] "Lung Carcinoma: Tumors of the Lungs". Merck Manual Professional Edition, Online edition. Retrieved 15 August 2007.

5 [4] Love, R. R., Leventhal, H., Easterling, D. V. and Nerenz, D. R. (1989), Side effects and emotional distress during cancer chemotherapy. Cancer, 63: doi: / ( )63:3<604::AID-CNCR >3.0.CO;2-2 [5] Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: Diagnosis and management. Am Fam Physician.2007;75: [PubMed] [6] Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, et al. Adrenal lesions: Characterization with fused PET/CT image in patients with proved or suspected malignancy Initial experience. Radiology. 2006;238: [PubMed] [7] Junker K, Thomas M, Schulmann K, Klinke F, Bosse U, Müller KM. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol.1997;123: [PubMed]

Management of Gastric Cancer Patient with Combination of Herbomineral Rasayana Therapy and Chemotherapy A Case Report

Management of Gastric Cancer Patient with Combination of Herbomineral Rasayana Therapy and Chemotherapy A Case Report Rasamruta -7:11,June 2015 Management of Gastric Cancer Patient with Combination of Herbomineral Rasayana Therapy and Chemotherapy A Case Report Yogesh Bendale,VineetaBendale,Poonam Birari-Gawande,AvinashKadam,Pravin

More information

Rasamruta, 7:13 July 2015

Rasamruta, 7:13 July 2015 Rasamruta, 7:13 July 2015 Survival Benefit in a Patient with Advanced Poorly Differentiated Adenocarcinoma of Lungs with Extensive Bone Metastasis with Ayurvedic Rasayan Therapy-A Case Report Yogesh Bendale,

More information

Overall Survival Benefit in Intrahepatic Cholangiocarcinoma with Rasayana Therapy A Case Report

Overall Survival Benefit in Intrahepatic Cholangiocarcinoma with Rasayana Therapy A Case Report Rasamruta - 8:1, January 2016 Overall Survival Benefit in Intrahepatic Cholangiocarcinoma with Rasayana Therapy A Case Report Yogesh Bendale, Vineeta Bendale,Poonam Birari-Gawande, Avinash Kadam and Pravin

More information

PET CT for Staging Lung Cancer

PET CT for Staging Lung Cancer PET CT for Staging Lung Cancer Rohit Kochhar Consultant Radiologist Disclosures Neither I nor my immediate family members have financial relationships with commercial organizations that may have a direct

More information

Lung Cancer Staging: The Revised TNM Classification

Lung Cancer Staging: The Revised TNM Classification Norwegian Society of Thoracic Imaging Oslo, October 2011 Lung Cancer Staging: The Revised TNM Classification Sujal R Desai King s College Hospital, London Lung Cancer The Scale of the Problem Leading cause

More information

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Lung Cancer Imaging Terence Z. Wong, MD,PhD Department of Radiology Duke University Medical Center Durham, NC 9/9/09 Acknowledgements Edward F. Patz, Jr., MD Jenny Hoang, MD Ellen L. Jones, MD, PhD Lung

More information

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.

More information

Colorectal Cancer and FDG PET/CT

Colorectal Cancer and FDG PET/CT Hybrid imaging in colorectal & esophageal cancer Emmanuel Deshayes IAEA WorkShop, November 2017 Colorectal Cancer and FDG PET/CT 1 Clinical background Cancer of the colon and rectum is one of the most

More information

Clinical Management Guideline for Small Cell Lung Cancer

Clinical Management Guideline for Small Cell Lung Cancer Diagnosis and Staging: Key Points 1. Ensure a CT scan that is

More information

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma. Case Scenario 1 An 89 year old male patient presented with a progressive cough for approximately six weeks for which he received approximately three rounds of antibiotic therapy without response. A chest

More information

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Radiological staging of lung cancer Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh Bronchogenic Carcinoma Accounts for 14% of new cancer diagnoses in 2012. Estimated to kill ~150,000

More information

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy. History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12

More information

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo Lung Cancer-a primer Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo CLINICAL CATEGORIES THE SOLITARY PULMONARY NODULE MULTIPLE PULMONARY NODULES Differential Diagnosis Malignant

More information

Tumor Board Discussions: Case 1

Tumor Board Discussions: Case 1 Tumor Board Discussions: Case 1 David S. Ettinger, MD The Alex Grass Professor of Oncology Johns Hopkins University School of Medicine Baltimore, Maryland Case #1 50-year-old Asian female, never smoker

More information

Mediastinal Staging. Samer Kanaan, M.D.

Mediastinal Staging. Samer Kanaan, M.D. Mediastinal Staging Samer Kanaan, M.D. Overview Importance of accurate nodal staging Accuracy of radiographic staging Mediastinoscopy EUS EBUS Staging TNM Definitions T Stage Size of the Primary Tumor

More information

Thursday, March 17, pm ET

Thursday, March 17, pm ET Virtual Molecular Tumor Board Host: MedStar Georgetown University Hospital Leader: Dr. John Marshall Thursday, March 17, 2016 5 pm ET Patient 1 The information contained in these slides is provided for

More information

Lung cancer in patients with chronic empyema

Lung cancer in patients with chronic empyema Lung cancer in patients with chronic empyema Poster No.: P-0025 Congress: ESTI 2015 Type: Scientific Poster Authors: Y. Lee, C.-K. Park; Guri/KR Keywords: Neoplasia, Biopsy, PET-CT, CT, Thorax, Lung DOI:

More information

ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND. Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London

ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND. Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London CANCER Key facts Estimated 15.2 million new cases per year in 2015 worldwide

More information

GUIDELINES FOR CANCER IMAGING Lung Cancer

GUIDELINES FOR CANCER IMAGING Lung Cancer GUIDELINES FOR CANCER IMAGING Lung Cancer Greater Manchester and Cheshire Cancer Network Cancer Imaging Cross-Cutting Group April 2010 1 INTRODUCTION This document is intended as a ready reference for

More information

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University LUNG CANCER Agnieszka Słowik, MD Department of Oncology, University Hospital in Cracow Jagiellonian University Epidemiology Most common malignancy worldwide Place of lung cancer among other malignancies

More information

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer

North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer THIS DOCUMENT IS North of Scotland Cancer Network Clinical Management Guideline for Non Small Cell Lung Cancer [Based on WOSCAN NSCLC CMG with further extensive consultation within NOSCAN] UNCONTROLLED

More information

THORACIC MALIGNANCIES

THORACIC MALIGNANCIES THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS

More information

Atypical Presentations of lung cancers

Atypical Presentations of lung cancers 8 Original Article Atypical Presentations of lung cancers PVV Bharadwaj, VV Ramana Reddy, Ganeswar Behera, JV Praveen, DSS Sowjanya, B Krishna Prithvi Abstract: Aim: The aim of this study was to examine

More information

Radiology Pathology Conference

Radiology Pathology Conference Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights

More information

Respiratory Interactive Session. Elaine Borg

Respiratory Interactive Session. Elaine Borg Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal

More information

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,

More information

PET/CT in breast cancer staging

PET/CT in breast cancer staging PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?

More information

Chirurgie beim oligo-metastatischen NSCLC

Chirurgie beim oligo-metastatischen NSCLC 24. Ärzte-Fortbildungskurs in Klinischer Onkologie 20.-22. Februar 2014, Kantonsspital St. Gallen Chirurgie beim oligo-metastatischen NSCLC Prof. Dr. med. Walter Weder Klinikdirektor Thoraxchirurgie, UniversitätsSpital

More information

IAEA RTC. PET/CT and Planning of Radiation Therapy 20/08/2014. Sarajevo (Bosnia & Hercegovina) Tuesday, June :40-12:20 a.

IAEA RTC. PET/CT and Planning of Radiation Therapy 20/08/2014. Sarajevo (Bosnia & Hercegovina) Tuesday, June :40-12:20 a. IAEA RTC PET/CT and Planning of Radiation Therapy Sarajevo (Bosnia & Hercegovina) Tuesday, June 17 2014 11:40-12:20 a.m María José García Velloso Servicio de Medicina Nuclear Clínica Universidad de Navarra

More information

Citation for published version (APA): van Kruchten, M. (2015). Molecular imaging of estrogen receptors [Groningen]: University of Groningen

Citation for published version (APA): van Kruchten, M. (2015). Molecular imaging of estrogen receptors [Groningen]: University of Groningen University of Groningen Molecular imaging of estrogen receptors van Kruchten, Michel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please

More information

GROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding:

GROUP 1: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases. Including: Excluding: GROUP 1: Including: Excluding: Peripheral tumour with normal hilar and mediastinum on staging CT with no disant metastases Solid pulmonary nodules 8mm diameter / 300mm3 volume and BROCK risk of malignancy

More information

The Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL

The Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL The Various Methods to Biopsy the Lung PROF SHITRIT DAVID HEAD, PULMONARY DEPARTMENT MEIR MEDICAL CENTER, ISRAEL Conflict of Interest This presentation is supported by AstraZeneca Two main steps before

More information

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer Poster No.: C-0654 Congress: ECR 2011 Type: Scientific Paper Authors:

More information

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded. Lung Case Scenario 1 A 54 year white male presents with a recent abnormal CT of the chest. The patient has a history of melanoma, kidney, and prostate cancers. 10/24/13 Chest X-ray: 2.9 cm mass like density

More information

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Dr Ian Chau Consultant Medical Oncologist Women's cancers Breast cancer introduction 3 What profession are you in?

More information

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer Locoregional (N stage) disease was redefined in the seventh edition of the AJCC Cancer Staging Manual as any periesophageal lymph

More information

Lung Cancer Case Study

Lung Cancer Case Study Lung Cancer Case Study Presented by s GP Education Programme 2 Part One Initial presentation 60 year old lady, presents with a 6 week history of right sided chest pain. The pain is like a dull ache, but

More information

THE EFFECT OF USING PET-CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC

THE EFFECT OF USING PET-CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC THE EFFECT OF USING PET-CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC Hana Al-Mahasneh,M.D*., Mohammad Khalaf Al-Fraessan, M.R.N,

More information

All India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology

All India Institute of Medical Sciences, New Delhi, INDIA. Department of Pediatric Surgery, Medical Oncology, and Radiology All India Institute of Medical Sciences, New Delhi, INDIA Department of Pediatric Surgery, Medical Oncology, and Radiology Clear cell sarcoma of the kidney- rare renal neoplasm second most common renal

More information

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017 Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations

More information

How to Analyse Difficult Chest CT

How to Analyse Difficult Chest CT How to Analyse Difficult Chest CT Complex diseases are:- - Large lesion - Unusual or atypical pattern - Multiple discordant findings Diffuse diseases are:- - Numerous findings in both sides 3 basic steps

More information

Imaging of cardio-pulmonary treatment related damage. Radiotheraphy and Lung

Imaging of cardio-pulmonary treatment related damage. Radiotheraphy and Lung Imaging of cardio-pulmonary treatment related damage Dr. Andrea Borghesi Dr. Emanuele Gavazzi Department of Radiology 2 University of Brescia Radiotheraphy and Lung The goal of radiation therapy (RT) is

More information

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010 Self Assessment Module on Nuclear Medicine and PET/CT Case Review FDG PET/CT IN LYMPHOMA AND MELANOMA Submitted

More information

RECTAL CANCER CLINICAL CASE PRESENTATION

RECTAL CANCER CLINICAL CASE PRESENTATION RECTAL CANCER CLINICAL CASE PRESENTATION Francesco Sclafani Medical Oncologist, Clinical Research Fellow The Royal Marsden NHS Foundation Trust, London, UK esmo.org Disclosure I have nothing to declare

More information

ES-SCLC Joint Case Conference. Anthony Paravati Adam Yock

ES-SCLC Joint Case Conference. Anthony Paravati Adam Yock ES-SCLC Joint Case Conference Anthony Paravati Adam Yock Case 57 yo woman with 35 pack year smoking history presented with persistent cough and rash Chest x-ray showed a large left upper lobe/left hilar

More information

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand

More information

Boot Camp Case Scenarios

Boot Camp Case Scenarios Boot Camp Case Scenarios Case Scenario 1 Patient is a 69-year-old white female. She presents with dyspnea on exertion, cough, and right rib pain. Patient is a smoker. 9/21/12 CT Chest FINDINGS: There is

More information

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical

More information

Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma Lung: An Unusual Presentation

Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma Lung: An Unusual Presentation Human Journals Research Article April 2017 Vol.:6, Issue:2 All rights are reserved by Dr Venkata Pradeep Babu Koyyala et al. Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT.

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT. Clinical summary Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT. For restaging PET/CT. PET/CT findings No significant FDG uptake

More information

PLACE LABEL HERE. Radiation Therapy Oncology Group Phase II - SBRT - Medically Inoperable I /II NSCLC Follow-up Form. RTOG Study No.

PLACE LABEL HERE. Radiation Therapy Oncology Group Phase II - SBRT - Medically Inoperable I /II NSCLC Follow-up Form. RTOG Study No. Radiation Therapy Oncology Group Phase II - SBRT - Medically Inoperable I /II NSCLC Follow-up Form RTOG Study No. 0813 Case # Name RTOG Patient ID INSTRUCTIONS: Submit this form at the appropriate followup

More information

For personal use only. Not to be reproduced without permission of the editor

For personal use only. Not to be reproduced without permission of the editor For personal use only. Not to be reproduced without permission of the editor (permissions@pharmj.org.uk) An overview of lung cancer November is Lung Cancer Awareness Month. With public smoking bans springing

More information

Bronchogenic Carcinoma

Bronchogenic Carcinoma A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most

More information

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay A 64 y.o. man presents to the hospital with persistent cough and hemoptysis Fernando Mut Montevideo - Uruguay Teaching case Bone # 1 A 64 y.o. man presents to the hospital with persistent cough and hemoptysis.

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Dr Sneha Shah Tata Memorial Hospital, Mumbai. Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas

More information

Guideline for the Management of Vulval Cancer

Guideline for the Management of Vulval Cancer Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11

More information

Ryan Niederkohr, M.D. Slides are not to be reproduced without permission of author

Ryan Niederkohr, M.D. Slides are not to be reproduced without permission of author Ryan Niederkohr, M.D. CMS: PET/CT CPT CODES 78814 Limited Area (e.g., head/neck only; chest only) 78815 78816 Regional (skull base to mid-thighs) True Whole Body (skull vertex to feet) SELECTING FIELD

More information

Common things are common, but not always the answer

Common things are common, but not always the answer Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Published Evidence. Hicks C, Foss AJE, Hungerford JL: Predictive power of screening tests for metastasis in uveal melanoma. Eye 12: , 1998

Published Evidence. Hicks C, Foss AJE, Hungerford JL: Predictive power of screening tests for metastasis in uveal melanoma. Eye 12: , 1998 Published Evidence Hicks C, Foss AJE, Hungerford JL: Predictive power of screening tests for metastasis in uveal melanoma. Eye 12:945-948, 1998 245 patients UM screened at diagnosis with FBC, LFT, CXR,

More information

American College of Radiology ACR Appropriateness Criteria

American College of Radiology ACR Appropriateness Criteria American College of Radiology ACR Criteria Radiologic Management of Thoracic Nodules and Masses Variant 1: Middle-aged patient (35 60 years old) with an incidental 1.5-cm lung nodule. The lesion was smooth.

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83

NICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83 Oesophago-gastric cancer: assessment and management in adults NICE guideline Published: 24 January 18 nice.org.uk/guidance/ng83 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Philadelphia College of Osteopathic Medicine. Dara Colasurdo Philadelphia College of Osteopathic Medicine,

Philadelphia College of Osteopathic Medicine. Dara Colasurdo Philadelphia College of Osteopathic Medicine, Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2012 Does The Use Of Intravenous Zoledronic

More information

CT PET SCANNING for GIT Malignancies A clinician s perspective

CT PET SCANNING for GIT Malignancies A clinician s perspective CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset

More information

Management of Neck Metastasis from Unknown Primary

Management of Neck Metastasis from Unknown Primary Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough

More information

Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node

Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node 2012 66 5 417 421 Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node a b* a a a a a a a b ʼ 418 Horio et al. Acta Med. Okayama Vol.

More information

STAGING AND FOLLOW-UP STRATEGIES

STAGING AND FOLLOW-UP STRATEGIES ATHENS 4-6 October 2018 European Society of Urogenital Radiology STAGING AND FOLLOW-UP STRATEGIES Ahmet Tuncay Turgut, MD Professor of Radiology Hacettepe University, Faculty of Medicine Ankara 2nd ESUR

More information

Lung Cancer: Diagnosis, Staging and Treatment

Lung Cancer: Diagnosis, Staging and Treatment PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in your cells. Cells are the building blocks of your tissues. Tissues make up the organs of your

More information

PET in Rectal Carcinoma

PET in Rectal Carcinoma Case Report PET in Rectal Carcinoma Josefina Jofré M 1, Paulina Sierralta C 1, José Canessa G 1,2, Pamela Humeres A 3, Gabriel Castro M 4, Teresa Massardo V 1,4 1 Centro PET de Imágenes Moleculares, Hospital

More information

Role of PETCT in the management of untreated advanced squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx

Role of PETCT in the management of untreated advanced squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx International Journal of Otorhinolaryngology and Head and Neck Surgery Dutta A et al. Int J Otorhinolaryngol Head Neck Surg. 2018 Mar;4(2):526-531 http://www.ijorl.com pissn 2454-5929 eissn 2454-5937 Original

More information

Case 1: HER2 positive MBC. Sudeep Gupta Tata Memorial Centre

Case 1: HER2 positive MBC. Sudeep Gupta Tata Memorial Centre Case 1: HER2 positive MBC Sudeep Gupta Tata Memorial Centre 54/F, postmenopausal First came to TMC on 3/8/15 Diagnosed in Jan 2015 Right breast mass Bones (L5 & S1), lung, spleen (upfront MBC) IDC grade

More information

Clinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital

Clinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital Clinical Discussion Dr Pankaj Chaturvedi Professor and Surgeon Tata Memorial Hospital chaturvedi.pankaj@gmail.com 47/M/smoker Hopkins : Transglottic lesion No cartilage infiltration but sclerosis Left

More information

Adam J. Hansen, MD UHC Thoracic Surgery

Adam J. Hansen, MD UHC Thoracic Surgery Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered

More information

Choroidal Metastases as the Initial Presentation of Lung Cancer: A Rare Scenario

Choroidal Metastases as the Initial Presentation of Lung Cancer: A Rare Scenario Case Report Choroidal Metastases as the Initial Presentation of Lung Cancer: A Rare Scenario S Shamim, S Vidya, SKH Kabir, B Ghosh Department of Pulmonary Medicine, Calcutta National Medical College and

More information

PET/CT in lung cancer

PET/CT in lung cancer PET/CT in lung cancer Andrei Šamarin North Estonia Medical Centre 3 rd Baltic Congress of Radiology 08.10.2010 Imaging in lung cancer Why do we need PET/CT? CT is routine imaging modality for staging of

More information

Prognostic factors in squamous cell anal cancers

Prognostic factors in squamous cell anal cancers Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus

More information

Educational Objectives. Managing Lung Cancer From the Solitary Pulmonary Nodule to Complex Cases: A Multidisciplinary Approach.

Educational Objectives. Managing Lung Cancer From the Solitary Pulmonary Nodule to Complex Cases: A Multidisciplinary Approach. Managing Lung Cancer From the Solitary Pulmonary Nodule to Complex Cases: A Multidisciplinary Approach Robert A. Meguid, MD, MPH, FACS Assistant Professor of Cardiothoracic Surgery Surgical Director, Surgical

More information

Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure

Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure ISPUB.COM The Internet Journal of Pathology Volume 19 Number 1 Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure A Julai, G Wathuge Citation A Julai, G Wathuge. Aggressive

More information

How to Manage Esophagus Cancer Patients with ct3n0m0, stage III Disease?

How to Manage Esophagus Cancer Patients with ct3n0m0, stage III Disease? How to Manage Esophagus Cancer Patients with ct3n0m0, stage III Disease? Case Number: RT2009-05(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor Purpose: to present a case

More information

Radiotherapy Physics and Equipment

Radiotherapy Physics and Equipment Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied

More information

An Update: Lung Cancer

An Update: Lung Cancer An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology

More information

Spectrum of Radiological Findings in Bronchogenic Carcinoma A Retrospective Study

Spectrum of Radiological Findings in Bronchogenic Carcinoma A Retrospective Study IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. VIII January. (2018), PP 43-59 www.iosrjournals.org Spectrum of Radiological Findings

More information

Might Adaptive Radiotherapy in NSCLC be feasible in clinical practice?

Might Adaptive Radiotherapy in NSCLC be feasible in clinical practice? Might Adaptive Radiotherapy in NSCLC be feasible in clinical practice? E.Molfese, P.Matteucci, A.Iurato, L.E.Trodella, A.Sicilia, B.Floreno, S.Ramella, L.Trodella Radioterapia Oncologica, Università Campus

More information

An Introduction to Radiology for TB Nurses

An Introduction to Radiology for TB Nurses An Introduction to Radiology for TB Nurses Garold O. Minns, MD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Garold O. Minns, MD has the following disclosures

More information

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP ESMO-Christie Lung Cancer Course Manchester 2017 Overview What is Endobronchial Ultrasound? Why & When Do We

More information

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior

More information

Case Report Solitary Osteolytic Skull Metastasis in a Case of Unknown Primary Being latter Diagnosed as Carcinoma of Gall Bladder

Case Report Solitary Osteolytic Skull Metastasis in a Case of Unknown Primary Being latter Diagnosed as Carcinoma of Gall Bladder Cronicon OPEN ACCESS CANCER Case Report Solitary Osteolytic Skull Metastasis in a Case of Unknown Primary Being latter Diagnosed as Carcinoma of Gall Kartik Mittal 1, Rajaram Sharma 1, Amit Dey 1, Meet

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

L hyperfixation dans le suivi des lymphomes représente-t-elle toujours une maladie active?

L hyperfixation dans le suivi des lymphomes représente-t-elle toujours une maladie active? L hyperfixation dans le suivi des lymphomes représente-t-elle toujours une maladie active? Thierry Vander Borght UCL Mont-Godinne, Belgique FDG-PET in Lymphoma: Mont-Godinne Experience 03/2000 10/2002:

More information

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES

MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES MEASUREMENT OF EFFECT SOLID TUMOR EXAMPLES Although response is not the primary endpoint of this trial, subjects with measurable disease will be assessed by standard criteria. For the purposes of this

More information

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context

More information